biote Corp.

biote Corp., formerly trading under the SPAC ticker HYAC as Haymaker Acquisition Corp. II, completed its business combination in June 2022 and subsequently traded on Nasdaq under the ticker BTMD. The SPAC was sponsored by Haymaker Sponsors II LLC and completed its initial public offering in 2020. biote operates in the healthcare and wellness sector, specifically providing bioidentical hormone replacement therapy training, practice support, and related services to physician practices across the United States. The June 2022 8-K filing, accession number 0001193125-22-171158, corresponds to significant corporate events surrounding the closing of the de-SPAC transaction. Visit SpacDesk and sign up for full data, filings, and analytics on biote Corp. and hundreds of other SPAC deals.